Eleonora Fois
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors
Angela CoronaSecondo
;Simona Distinto;Alessia Caredda;Elias Maccioni;Enzo TramontanoPenultimo
;
2019-01-01
Abstract
The paper focussed on a step-by-step structural modification of a cycloheptathiophene-3-carboxamide derivative recently identified by us as reverse transcriptase (RT)-associated ribonuclease H (RNase H) inhibitor. In particular, its conversion to a 2-aryl-cycloheptathienoozaxinone derivative and the successive thorough exploration of both 2-aromatic and cycloheptathieno moieties led to identify oxazinone-based compounds as new anti-RNase H chemotypes. The presence of the catechol moiety at the C-2 position of the scaffold emerged as critical to achieve potent anti-RNase H activity, which also encompassed anti-RNA dependent DNA polymerase (RDDP) activity for the tricyclic derivatives. Benzothienooxazinone derivative 22 resulted the most potent dual inhibitor exhibiting IC50s of 0.53 and 2.90 lM against the RNase H and RDDP functions. Mutagenesis and docking studies suggested that compound 22 binds two allosteric pockets within the RT, one located between the RNase H active site and the primer grip region and the other close to the DNA polymerase catalytic centre.File | Dimensione | Formato | |
---|---|---|---|
post-refeering.pdf accesso aperto
Descrizione: Bozza sottomesssa, versione post-referaggio
Tipologia: versione post-print
Dimensione 1.75 MB
Formato Adobe PDF
|
1.75 MB | Adobe PDF | Visualizza/Apri |
From cycloheptathiophene 3 carboxamide to oxazinone based derivatives as allosteric HIV 1 ribonuclease H inhibitors.pdf accesso aperto
Tipologia: versione editoriale
Dimensione 3.31 MB
Formato Adobe PDF
|
3.31 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.